Literature DB >> 21873622

Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity.

Marijke C Trappenburg1, Muriel van Schilfgaarde, Fenneke C P Frerichs, Henri M H Spronk, Hugo ten Cate, Carola W H de Fijter, Wim E Terpstra, Anja Leyte.   

Abstract

BACKGROUND: In patients with chronic renal failure (CRF), cardiovascular disease is the leading cause of increased morbidity and mortality. We hypothesized a role for endothelial activation and microparticle (MP) numbers and procoagulant activity in the pre-thrombotic state of these patients.
METHODS: We analysed blood samples of 27 patients with CRF [8 chronic kidney disease Stage 4 (CKD4), 9 peritoneal dialysis (PD) and 10 haemodialysis (HD), samples taken before and after HD] and 10 controls. Degree and nature of endothelial activation were assessed by measuring mature von Willebrand factor (vWF) and vWF propeptide levels. Cellular MPs were characterized by flow cytometry and MP-specific thrombin generation (TG) measurements.
RESULTS: CRF was accompanied by chronic (CKD4 and PD) or acute (HD) endothelial activation. Patients with CRF had substantially higher MP numbers than controls (median 9400 versus 4350×10(6)/L, P=0.001), without significant differences between the treatment subgroups or between pre- and post-HD. The vast majority of MPs were platelet derived. Of the minor populations, endothelial MPs and tissue factor-bearing MPs were more abundant in CRF. MPs were procoagulant, but the increase in numbers was not reflected in a proportional increase in MP-specific TG.
CONCLUSION: Renal failure is accompanied by endothelial activation of a different nature in CKD4 and PD patients compared to HD patients, and results in all subgroups in an increase of mainly platelet-derived MPs that appear to be less procoagulant than in other disease states, possibly because of the uraemic functional defect of their cellular source.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873622     DOI: 10.1093/ndt/gfr474

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  24 in total

Review 1.  Extracellular vesicles in renal disease.

Authors:  Diana Karpman; Anne-Lie Ståhl; Ida Arvidsson
Journal:  Nat Rev Nephrol       Date:  2017-07-24       Impact factor: 28.314

2.  The importance of studying red blood cells microparticles.

Authors:  Andrea Piccin; Muriel Van Schilfgaarde; Owen Smith
Journal:  Blood Transfus       Date:  2014-11-18       Impact factor: 3.443

3.  High intensity cycling before SCUBA diving reduces post-decompression microparticle production and neutrophil activation.

Authors:  Dennis Madden; Stephen R Thom; Ming Yang; Veena M Bhopale; Marko Ljubkovic; Zeljko Dujic
Journal:  Eur J Appl Physiol       Date:  2014-06-11       Impact factor: 3.078

Review 4.  Extracellular vesicles as mediators of vascular inflammation in kidney disease.

Authors:  Alexandra Helmke; Sibylle von Vietinghoff
Journal:  World J Nephrol       Date:  2016-03-06

Review 5.  Blood Cell-Derived Microvesicles in Hematological Diseases and beyond.

Authors:  Hara T Georgatzakou; Sotirios P Fortis; Effie G Papageorgiou; Marianna H Antonelou; Anastasios G Kriebardis
Journal:  Biomolecules       Date:  2022-06-08

6.  Cyclosporine induces endothelial cell release of complement-activating microparticles.

Authors:  Brandon Renner; Jelena Klawitter; Ryan Goldberg; James W McCullough; Viviana P Ferreira; James E Cooper; Uwe Christians; Joshua M Thurman
Journal:  J Am Soc Nephrol       Date:  2013-10-03       Impact factor: 10.121

Review 7.  Extracellular Vesicles in Renal Diseases: More than Novel Biomarkers?

Authors:  Uta Erdbrügger; Thu H Le
Journal:  J Am Soc Nephrol       Date:  2015-08-06       Impact factor: 10.121

8.  von Willebrand factor propeptide: biology and clinical utility.

Authors:  Sandra L Haberichter
Journal:  Blood       Date:  2015-07-27       Impact factor: 22.113

9.  Calcium-phosphate microprecipitates mimic microparticles when examined with flow cytometry.

Authors:  Michael C Larson; Maia R Luthi; Neil Hogg; Cheryl A Hillery
Journal:  Cytometry A       Date:  2012-11-02       Impact factor: 4.355

10.  Elevated levels of procoagulant plasma microvesicles in dialysis patients.

Authors:  James O Burton; Hassan A Hamali; Ruchir Singh; Nima Abbasian; Ruth Parsons; Amit K Patel; Alison H Goodall; Nigel J Brunskill
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.